Barclays’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-259,160
| Closed | -$881K | – | 4654 |
|
|
2018
Q3 | $881K | Buy |
259,160
+192,403
| +288% | +$654K | ﹤0.01% | 2325 |
|
|
2018
Q2 | $252K | Buy |
66,757
+23,616
| +55% | +$89.1K | ﹤0.01% | 2636 |
|
|
2018
Q1 | $176K | Sell |
43,141
-44,913
| -51% | -$183K | ﹤0.01% | 2909 |
|
|
2017
Q4 | $409K | Sell |
88,054
-48,561
| -36% | -$226K | ﹤0.01% | 2231 |
|
|
2017
Q3 | $970K | Buy |
136,615
+66,371
| +94% | +$471K | ﹤0.01% | 1610 |
|
|
2017
Q2 | $507K | Buy |
70,244
+43,795
| +166% | +$316K | ﹤0.01% | 1917 |
|
|
2017
Q1 | $164K | Buy |
26,449
+19,799
| +298% | +$123K | ﹤0.01% | 2612 |
|
|
2016
Q4 | $40K | Sell |
6,650
-34,904
| -84% | -$210K | ﹤0.01% | 2910 |
|
|
2016
Q3 | $221K | Buy |
41,554
+2,717
| +7% | +$14.5K | ﹤0.01% | 2093 |
|
|
2016
Q2 | $258K | Buy |
38,837
+18,656
| +92% | +$124K | ﹤0.01% | 2017 |
|
|
2016
Q1 | $81K | Buy |
20,181
+18,957
| +1,549% | +$76.1K | ﹤0.01% | 2388 |
|
|
2015
Q4 | $6K | Sell |
1,224
-24,413
| -95% | -$120K | ﹤0.01% | 2894 |
|
|
2015
Q3 | $78K | Buy |
25,637
+1,049
| +4% | +$3.19K | ﹤0.01% | 2454 |
|
|
2015
Q2 | $222K | Sell |
24,588
-2,217
| -8% | -$20K | ﹤0.01% | 2042 |
|
|
2015
Q1 | $322K | Buy |
26,805
+4,101
| +18% | +$49.3K | ﹤0.01% | 2105 |
|
|
2014
Q4 | $317K | Buy |
22,704
+6,848
| +43% | +$95.6K | ﹤0.01% | 2180 |
|
|
2014
Q3 | $206K | Buy |
15,856
+3,131
| +25% | +$40.7K | ﹤0.01% | 2312 |
|
|
2014
Q2 | $189K | Buy |
12,725
+1,744
| +16% | +$25.9K | ﹤0.01% | 2422 |
|
|
2014
Q1 | $187K | Sell |
10,981
-37,128
| -77% | -$632K | ﹤0.01% | 2421 |
|
|
2013
Q4 | $578K | Sell |
48,109
-41,245
| -46% | -$496K | ﹤0.01% | 2061 |
|
|
2013
Q3 | $893K | Buy |
89,354
+36,947
| +71% | +$369K | ﹤0.01% | 1762 |
|
|
2013
Q2 | $392K | Buy |
+52,407
| New | +$392K | ﹤0.01% | 2347 |
|